Active, not recruitingNot applicableNCT02263781
PREPL in Health and Disease
Studying Homozygous 2p21 microdeletion syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Principal Investigator
- Luc Régal, MDKU Leuven
- Intervention
- Blood draw(procedure)
- Enrollment
- 125 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2014 – 2025
Study locations (1)
- UZLeuven, Leuven, Belgium
Collaborators
KU Leuven
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02263781 on ClinicalTrials.gov